Investment case
Carlsmed, Inc.
CARL · 3 developments mapped · last assessed 2026-09-16
Market Ontology has mapped 3 macro, policy, and market developments to Carlsmed, Inc. since 2026-09-16. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for CARL yet, so no modelled value is shown. The CARL valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run CARL on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Carlsmed Files Federal Patent Suit Against DeGen Medical Over AI Spine Implants
Legal action outcome, intellectual property protection, competitive landscape
· Moves future revenue growth rate, operating expenses (legal costs), market share potential
What changed, by assumption
- 2026-09-16Carlsmed Files Federal Patent Suit Against DeGen Medical Over AI Spine Implants
- 2026-09-16Carlsmed files federal patent infringement lawsuit against DeGen Medical
- 2026-09-16Carlsmed Sues DeGen Medical Over AI-Enabled Personalized Spine Patents
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-16 | Carlsmed files federal patent infringement lawsuit against DeGen Medical | mixed | 3-12m | 0.60 |
| 2026-09-16 | Carlsmed Sues DeGen Medical Over AI-Enabled Personalized Spine Patents | mixed | 3-12m | 0.60 |
| 2026-09-16 | Carlsmed Files Federal Patent Suit Against DeGen Medical Over AI Spine Implants | mixed | 3-12m | 0.70 |